{"status":"success","data":{"title":"Bell's Palsy Treatment","slug":"bells-palsy-treatment","tags":["Valacylovir","Acyclovir","Prednisone"],"collection":["Neurology"],"content":"\n# Bell's Palsy: Treatment\n\n**Treatment**\n\nCorticosteroids, if onset within 72 hours\n\n1.  **<span class=\"drug\">Prednisone</span>** 60 daily x 1 week. May consider taper for days \\#8-10\n2.   NNT.com: 1 in 11 were helped (to complete recovery)\n\n Controversial benefit of antivirals (at most risk difference of 7%): American Academy of Neurology (2012), JAMA (2009), and UpToDate suggest giving for severe cases such as for Grade IV and higher \n\n1.  Cochrane review (2009): No antivirals indicated. \n2.  **<span class=\"drug\">Valacylovir**</span> 1000 mg TID or **<span class=\"drug\">Acyclovir**</span> 400 mg 5x daily x 1 week\n3.  Also prescribe <span class=\"drug\">corticosteroids</span>, if antivirals given.\n\n<span class=\"drug\">Artificial tears</span> in daytime and lubricating eye ointment at night to prevent corneal drying and exposure. Tape eyelid shut while asleep.\n\n## House-Brackmann grading for severity of facial nerve weakness\n\n|  Grade | Dysfunction       | Gross weakness  | At rest |  Motion  |\n|--------|-------------------|-------------|-------------------|----------------|\n| I      | None              | No weakness | No weakness       | Normal function all groups |\n| II     | Mild              | Slight weakness noticeable on close inspection. May have very slight synkinesis  | Normal symmetry and tone | **Forehead**: Moderate-to-good function  **Mouth**: Slight asymmetry   |\n| III    | Moderate          | Obvious but not disfiguring difference; noticeable but not severe synkinesis, contracture, and/or hemifacial spasm | Normal symmetry and tone | **Forehead**: Slight-to-moderate movement  **Mouth**: Slightly weak with maximum effort   |\n| IV     | Moderately severe | Obvious weakness and/or disfiguring asymmetry                                                                      | Normal symmetry and tone | **Forehead**: None  **Mouth**: Asymmetric with maximum effort      |\n| V      | Severe            | Only barely perceptible motion                                                                                     | Asymmetry                | **Forehead**: None      **Mouth**: Slight movement                     |\n| VI     | Total paralysis   | No movement                                                                                                        | Asymmetry                | None for all groups                           |\n\n## References\n\n-   [Gronseth GS, Paduga R; American Academy of Neurology. Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2012 Nov 27;79(22):2209-13. doi: 10.1212/WNL.0b013e318275978c. Epub 2012 Nov 7.](https://www.ncbi.nlm.nih.gov/pubmed/23136264)\n-   [de Almeida JR, Al Khabori M, Guyatt GH, Witterick IJ, Lin VY, Nedzelski JM, Chen JM. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA. 2009 Sep 2;302(9):985-93. doi: 10.1001/jama.2009.1243.](https://www.ncbi.nlm.nih.gov/pubmed/?term=19724046)\n-   [Lockhart P, Daly F, Pitkethly M, Comerford N, Sullivan F. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2009 Oct 7;(4):CD001869. doi: 10.1002/14651858.CD001869.pub4.](https://www.ncbi.nlm.nih.gov/pubmed/19821283)\n"}}